Showing results (1391-1400 of 5,932) with videos related to

Sort By:
Pageof 594
The Prostate|October 5, 2023
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancerMark P Labrecque, Lisha G Brown, Ilsa M Coleman, et al.
The Prostate|October 15, 2023
Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJRaphaela Dos Santos Menezes, Maria Cristina Dornas, Carlos Frederico Ferreira Campos, et al.
The Prostate|July 3, 2023
PSMA PET-based stereotactic body radiotherapy for locally recurrent prostate cancer after definitive first-line therapyArne Gruen, Katharina Tegel, Anne Kluge, et al.
The Prostate|July 7, 2023
Late puberty onset and lack of acne during adolescence reduce high-grade prostate cancer at adulthoodJesús Gibran Hernández-Pérez, David S López, Rocío Rodríguez-Valentín, et al.
The Prostate|August 10, 2023
Third generation quinoline-3-carboxamide transcriptional disrupter of HDAC4, HIF-1α, and MEF-2 signaling for metastatic castration-resistant prostate cancerJohn T Isaacs, Susan L Dalrymple, Lizamma Antony, et al.
The Prostate|July 28, 2023
Evidence for a causal effect of major depressive disorder, anxiety on prostatitis risk: A univariate and multivariate Mendelian randomization studyYong Zhang, Rui Peng, Zhan Chen, et al.
The Prostate|August 25, 2023
Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?Mason J Belue, Zoë Blake, Enis C Yilmaz, et al.
The Prostate|September 4, 2023
The role of PSMA PET/CT to predict upgrading in patients undergoing radical prostatectomy for ISUP grade group 1 prostate cancerBaris Esen, Hulya Seymen, Bengi Gurses, et al.
The Prostate|September 27, 2023
Nanomechanical-based classification of prostate tumor using atomic force microscopyJinshu Zeng, Yan Zhang, Renfeng Xu, et al.
The Prostate|August 21, 2023
The effect of tranexamic acid on perioperative blood loss in transurethral resection of the prostate: A double-blind, randomized controlled trialWies Vanderbruggen, Tim Brits, Sam Tilborghs, et al.
Pageof 594